Age restrictions on AstraZeneca shot have ended reports of rare clots

No new cases of rare and severe blood clots following vaccination with AstraZeneca's Covid-19 shot have been reported in Britain in recent weeks after a decision to restrict its use in under-40s, British scientists said on Wednesday.

Vaccine-induced immune thrombocytopenia and thrombosis (VITT) is a combination of blot clots and low platelet levels which have been labelled as a rare side effect of the viral vector Covid vaccines made by AstraZeneca and Johnson & Johnson...